Gregory Conko is a Senior Fellow at the Competitive Enterprise Institute, a Washington, DC-based public interest group. His research at CEI focuses on issues of food and pharmaceutical drug safety regulation, and on the general treatment of health risks in public policy. He is particularly interested in the debate over the safety of biotechnology and bioengineered foods, as well as the application of the Precautionary Principle to domestic and international environmental and safety regulations.
Mr. Conko is also the Vice President and a member of the
Board of Directors of the Auburn, Alabama-based AgBioWorld Foundation, a
non-profit organization he co-founded in 2000 with
Mr. Conko’s book, The Frankenfood Myth: How Protest and Politics Threaten the Biotech Revolution (Praeger, 2004), co-authored with Henry I. Miller, was named by Barron’s as one of the 25 best books of 2004. His other writings have appeared in such journals as Nature Biotechnology, Transgenic Research, Politics and the Life Sciences, the Richmond Journal of Law & Technology, and the Cumberland Law Review, and in such newspapers as the Financial Times, The Wall Street Journal Europe and Asian Wall Street Journal, Los Angeles Times, and the San Francisco Chronicle. He has appeared on numerous television and radio programs as a commentator on public health and consumer safety issues, and he frequently participates in international meetings on food safety and trade as a credentialed Non-Governmental Organization representative.
Mr. Conko is a member of the Board of Scientific and Policy
Advisors for the New York-based American Council on Science and Health. He
served as a principal investigator for the California Council on Science and
Technology’s 2002 report Benefits and
Risks of Food Biotechnology. He was selected by the American Swiss
Foundation as one of 25 Young Leaders from the
Prior to joining CEI in 1994, Mr. Conko was a Research
Associate with the
Book as Speaker
Read All Publications by Expert.
recent op-eds & articles
FDA's Bad Medicine
By Gregory Conko, Jerome Arnett, June 17, 2009
Will Americans (Literally) Be Dying For ObamaCare?
By Gregory Conko, Henry I. Miller, June 12, 2009
Supreme Court Botches Preemption Case
By Gregory Conko, April 1, 2009
Needle and the Damage Done
By Gregory Conko, March 18, 2009
Sick Patients Need Cutting-Edge Drugs
By Gregory Conko, August 23, 2008
recent studies
Black Box Panic
By Gregory Conko, Jerome Arnett, March 3, 2009
FDA's Bad Medicine
By Gregory Conko, Jerome Arnett, August 13, 2008
Drug Reimportation's Dangerous Allure
By Gregory Conko, April 24, 2008
Promoting Healthy Biopharmaceutical Competition
By Gregory Conko, November 28, 2007
Dying for FDA Reform
By Gregory Conko, June 20, 2007
news release
Supreme Court Botches Preemption Case
By Gregory Conko, March 4, 2009
The Frankenfood Myth: How Protest and Politics Threaten the Biotech Revolution
By Gregory Conko, Henry I. Miller, August 20, 2004
Scientists and Scholars Denounce Position of the Catholic Institute for International Relations on GM Crops
By Gregory Conko, July 19, 2004
CEI Comments Before FDA on Bioengineered Foods
By Gregory Conko, May 4, 2001
recent citations
Gregory Conko on FDA Drug approval delays; new drug called Provenge
Investor’s Business Daily, Apr. 24, 2009
Gregory Conko on Supreme Court’s decision in Wyeth v. Levine
ABC News, Mar. 4, 2009
Gregory Conko on the presidential candidates' views on the biotech industry
Pharmacy Choice, Oct. 6, 2008
Gregory Conko on FDA approval for "biogeneric" drugs
FDA News, Oct. 3, 2008

